Journals / Epilepsi / 2015 / Cilt: 21 - Sayı: 2

Drug Resistance and Resistance Mechanisms in Epilepsy

Epilepside İlaç Direnci ve Direnç Mekanizmaları

Journal
Epilepsi
Pages
43–53
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Contributing to this body of work, this article discusses drug resistance in epilepsy, its underlying mechanisms and accompanying clinical issues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epilepsy is a commonly encountered disorder among neurological disorders in our country and in the world.
📊
Key Findings & Data:Almost 30% of seizures persist in spite of medical treatment.
💡
Conclusion & Impact:Contributing to this body of work, this article discusses drug resistance in epilepsy, its underlying mechanisms and accompanying clinical issues.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Epilepsy is a commonly encountered disorder among neurological disorders in our country and in the world. Almost 30% of seizures persist in spite of medical treatment. Resistance to medical treatment is important with regard to cognitive and psychosocial problems, and increased risk in mortality and morbidity. It may emerge due to the type of epilepsy, underlying epileptogenic process, and individual differences. Immunological, genetic and plasticity-related mechanisms are most relevant. The literature related to this subject is growing constantly, and increased understanding of the underlying mechanisms of drug resistance will play an important role in the development of more efficient treatment strategies. Contributing to this body of work, this article discusses drug resistance in epilepsy, its underlying mechanisms and accompanying clinical issues.

Özet

Epilepsi ülkemizde ve dünyada sık görülen nörolojik hastalıklardan biridir. Hastaların yaklaşık %30’unda nöbetler ilaç tedavisine rağmen devam etmektedir. Tedaviye direnç kognitif ve psikososyal sorunlar ile mortalite ve morbidite riskinde artışa neden olması açısından önem taşımaktadır. Tedaviye direnç, epilepsi tipi, altta yatan epileptogenez süreci ve bireysel farklılıklar nedeni ile gelişebilir. Başlıca mekanizmalar immünolojik, genetik ve plastisite ile ilişkili olmak üzere dikkat çekmekte ve gün geçtikçe bilgi birikimimiz artmaktadır. Daha etkin tedavi ve yaklaşımlarının geliştirilebilmesi için, ilaç direncinin altında yatan mekanizmaların anlaşılması önem taşımaktadır. Bu amaçla, epilepside ilaç direnci, altta yatan mekanizmalar ile bunlara eşlik eden klinik sorunlar ele alınmıştır.

🔖

Cite This Article

TAŞKIRAN, E., BEBEK, N. (2015). Drug Resistance and Resistance Mechanisms in Epilepsy. Epilepsi, Cilt: 21 - Sayı: 2, 43–53. https://ajindex.com/articles/161397

References (15)

  1. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069–77
  2. Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61(5):433–43
  3. Perucca E. Pharmacoresistance in epilepsy: how should it be defined? CNS Drugs 1998;10:171–9
  4. Schmidt D, Löscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009;9(2):47–52
  5. Mohanraj R, Brodie MJ. Early predictors of outcome in newly diagnosed epilepsy. Seizure 2013;22(5):333–44
  6. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007;75(2-3):192–6
  7. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5(7):553–64
  8. Vreugdenhil M, van Veelen CW, van Rijen PC, Lopes da Silva FH, Wadman WJ. Effect of valproic acid on sodium currents in cortical neurons from patients with pharmaco-resistant temporal lobe epilepsy. Epilepsy Res 1998;32(1-2):309–20
  9. Vreugdenhil M, Wadman WJ. Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis. Epilepsia 1999;40(11):1512–22
  10. Remy S, Gabriel S, Urban BW, Dietrich D, Lehmann TN, Elger CE, et al. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 2003;53(4):469–79
  11. Remy S, Urban BW, Elger CE, Beck H. Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats. Eur J Neurosci 2003;17(12):2648–58
  12. Aronica E, Yankaya B, Troost D, van Vliet EA, Lopes da Silva FH, Gorter JA. Induction of neonatal sodium channel II and III alphaisoform mRNAs in neurons and microglia after status epilepticus in the rat hippocampus. Eur J Neurosci 2001;13(6):1261–6
  13. Curia G, Aracri P, Colombo E, Scalmani P, Mantegazza M, Avanzini G, et al. Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current. Br J Pharmacol 2007;150(6):792–7
  14. Gibbs JW 3rd, Shumate MD, Coulter DA. Differential epilepsyassociated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J Neurophysiol 1997;77(4):1924–38
  15. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes i